Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kevin, Brigle"'
Publikováno v:
Journal of the Advanced Practitioner in Oncology. 13:7-14
Multiple myeloma (MM) is an incurable plasma cell disorder that affects nearly 35,000 people annually. Over 149,000 individuals are estimated to live in the United States with MM. Research has generated a greater understanding of the pathology of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a883122628ffb95f4e95c21df25c36e
https://doi.org/10.6004/jadpro.2022.13.5.10
https://doi.org/10.6004/jadpro.2022.13.5.10
Autor:
Barbara B. Rogers, Kevin Brigle
Publikováno v:
Seminars in Oncology Nursing. 33:225-236
Objective To understand the role of the genetic changes and bone marrow microenvironment on the development, progression, and staging of multiple myeloma (MM). Data Sources Peer-reviewed articles and clinical guidelines. Conclusion The acquisition of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b61be7dfda29b71528b7ee1f8fc0b19f
https://doi.org/10.1016/j.soncn.2017.05.012
https://doi.org/10.1016/j.soncn.2017.05.012
Autor:
Kevin Brigle, Amy Pierre, Elizabeth Finley-Oliver, Beth Faiman, Joseph Tariman, Teresa Miceli, and Board
Publikováno v:
Clinical journal of oncology nursing. 21
Background Oncologic emergencies associated with multiple myeloma include myelosuppression (anemia, neutropenia, and thrombocytopenia), bone-related emergencies, and acute renal failure. . Objectives This article reviews the pathophysiology of these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8276427faa7f61ff7289cd9fe7cab41
https://pubmed.ncbi.nlm.nih.gov/28945730
https://pubmed.ncbi.nlm.nih.gov/28945730
Autor:
Page Bertolotti, Rn, Bsn, Ocn, NP Kevin Brigle, Sandra Kurtin, Rn, Msn, Aocn, Anp-C, Daniel Verina, Bs, Bsn, Msn, Acnp-Bc
Publikováno v:
Journal of the Advanced Practitioner in Oncology. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da170ae9f8a7f6d9726ea211b097a52d
https://doi.org/10.6004/jadpro.2016.7.2.15
https://doi.org/10.6004/jadpro.2016.7.2.15
Publikováno v:
Journal of the Advanced Practitioner in Oncology. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::305b749c9c298d6e6d93802b15d3c5d1
https://doi.org/10.6004/jadpro.2016.7.2.12
https://doi.org/10.6004/jadpro.2016.7.2.12
Autor:
Kevin Brigle
Publikováno v:
Journal of the Advanced Practitioner in Oncology. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e89c524defada8d13b62d06bdadb2322
https://doi.org/10.6004/jadpro.2016.7.2.17
https://doi.org/10.6004/jadpro.2016.7.2.17
Publikováno v:
Journal of Biological Chemistry. 273:25953-25960
L1210/D3 mouse leukemia cells are resistant to 5, 10-dideazatetrahydrofolate due to expansion of cellular folate pools which block polyglutamation of the drug (Tse, A., and Moran, R. G. (1998) J. Biol. Chem. 273, 25944-25952). These cells were found
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dac1d20af83fa125b77538023ac45454
https://doi.org/10.1074/jbc.273.40.25953
https://doi.org/10.1074/jbc.273.40.25953
Publikováno v:
Molecular and General Genetics MGG. 205:318-325
Tn5 was introduced into Azotobacter vinelandii on a suicide vector, pGS9. Three Nif- mutants were found to carry Tn5 in nifH (MV6), in nifN (MV22), and in or near nifM (MV21), from the results of hybridisation experiments. For MV21 and MV22 this was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::691af5fed0b88ae34b0a531dd0c11889
https://doi.org/10.1007/bf00430445
https://doi.org/10.1007/bf00430445